Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Scharf

Showing results (411-420 of 445) with videos related to

Pageof 45
Sort By:
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|September 8, 2019
Efficacy and safety of a biosimilar recombinant human growth hormone (r-hGH Cristalia) compared with reference r-hGH in children with growth hormone deficiency (CERES study): A randomized, multicentric, investigator-blind, phase 3 trialM A Czepielewski, Q Garret, S A C Vencio, et al.
Chest|November 14, 2006
Feasibility of retinoids for the treatment of emphysema studyMichael D Roth, John E Connett, Jeanine M D'Armiento, et al.
COPD|February 2, 2012
Influence of lightweight ambulatory oxygen on oxygen use and activity patterns of COPD patients receiving long-term oxygen therapyRichard Casaburi, Janos Porszasz, Ariel Hecht, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|December 1, 2020
Switching from originator recombinant growth hormone (Genotropin™) to biosimilar (CRISCY™): Results from a 6-month, multicentric, non-inferiority, extension trialM A Czepielewski, Q Garret, S A C Vencio, et al.
Respiratory Research|November 21, 2009
Eosinophil and T cell markers predict functional decline in COPD patientsJeanine M D'Armiento, Steven M Scharf, Michael D Roth, et al.
The New England Journal of Medicine|May 20, 2014
Simvastatin for the prevention of exacerbations in moderate-to-severe COPDGerard J Criner, John E Connett, Shawn D Aaron, et al.
COPD|February 9, 2011
Randomized trial of zileuton for treatment of COPD exacerbations requiring hospitalizationPrescott G Woodruff, Richard K Albert, William C Bailey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 2, 2012
Long-term comparative immunogenicity of protein conjugate and free polysaccharide pneumococcal vaccines in chronic obstructive pulmonary diseaseMark T Dransfield, Sarah Harnden, Robert L Burton, et al.
The New England Journal of Medicine|August 26, 2011
Azithromycin for prevention of exacerbations of COPDRichard K Albert, John Connett, William C Bailey, et al.
Plos One|March 28, 2013
CNV analysis in Tourette syndrome implicates large genomic rearrangements in COL8A1 and NRXN1Abhishek Nag, Elena G Bochukova, Barbara Kremeyer, et al.
Pageof 45

Showing results (411-420 of 445) with videos related to

Sort By:
Pageof 45
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|September 8, 2019
Efficacy and safety of a biosimilar recombinant human growth hormone (r-hGH Cristalia) compared with reference r-hGH in children with growth hormone deficiency (CERES study): A randomized, multicentric, investigator-blind, phase 3 trialM A Czepielewski, Q Garret, S A C Vencio, et al.
Chest|November 14, 2006
Feasibility of retinoids for the treatment of emphysema studyMichael D Roth, John E Connett, Jeanine M D'Armiento, et al.
COPD|February 2, 2012
Influence of lightweight ambulatory oxygen on oxygen use and activity patterns of COPD patients receiving long-term oxygen therapyRichard Casaburi, Janos Porszasz, Ariel Hecht, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|December 1, 2020
Switching from originator recombinant growth hormone (Genotropin™) to biosimilar (CRISCY™): Results from a 6-month, multicentric, non-inferiority, extension trialM A Czepielewski, Q Garret, S A C Vencio, et al.
Respiratory Research|November 21, 2009
Eosinophil and T cell markers predict functional decline in COPD patientsJeanine M D'Armiento, Steven M Scharf, Michael D Roth, et al.
The New England Journal of Medicine|May 20, 2014
Simvastatin for the prevention of exacerbations in moderate-to-severe COPDGerard J Criner, John E Connett, Shawn D Aaron, et al.
COPD|February 9, 2011
Randomized trial of zileuton for treatment of COPD exacerbations requiring hospitalizationPrescott G Woodruff, Richard K Albert, William C Bailey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 2, 2012
Long-term comparative immunogenicity of protein conjugate and free polysaccharide pneumococcal vaccines in chronic obstructive pulmonary diseaseMark T Dransfield, Sarah Harnden, Robert L Burton, et al.
The New England Journal of Medicine|August 26, 2011
Azithromycin for prevention of exacerbations of COPDRichard K Albert, John Connett, William C Bailey, et al.
Plos One|March 28, 2013
CNV analysis in Tourette syndrome implicates large genomic rearrangements in COL8A1 and NRXN1Abhishek Nag, Elena G Bochukova, Barbara Kremeyer, et al.
Pageof 45